| Literature DB >> 24416309 |
Michele L Callisaya1, Richard Beare2, Thanh G Phan2, Jian Chen2, Velandai K Srikanth1.
Abstract
BACKGROUND: Gait impairments increase with advancing age and can lead to falls and loss of independence. Brain atrophy also occurs in older age and may contribute to gait decline. We aimed to investigate global and regional relationships of cerebral gray and white matter volumes with gait speed, and its determinants step length and cadence, in older people.Entities:
Mesh:
Year: 2014 PMID: 24416309 PMCID: PMC3885624 DOI: 10.1371/journal.pone.0084909
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of Participants in the TASCOG (n = 305).
| Age, mean (SD) | 71.4 | (6.9) |
| Males, n (%) | 165 | (54.1) |
| Height (cm) | 166.9 | (9.3) |
| Weight (kg) | 77.1 | (14.3) |
| Diastolic blood pressure (mmHg) | 142.9 | (22.3) |
| Systolic blood pressure (mmHg) | 80.9 | (12.7) |
| Independent in activities of daily living (%) | 291 | (95.4) |
| Physical activity (steps per day), mean (SD) | 6293.3 | 3171.8 |
| Self-reported medical history | ||
| Hypertension, n (%) | 145 | (47.5) |
| Diabetes, n (%) | 26 | (8.5) |
| Ischemic heart disease, n (%) | 35 | (11.5) |
| Hypercholesterolemia, n (%) | 116 | (38.0) |
| Stroke | 16 | (5.3) |
| Ever smoker, n (%) | 152 | (49.8) |
| Arthritis, n (%) | 128 | (42.2) |
| Psychoactive medication, n (%) | 51 | 16.6% |
| Blood pressure lowering medication, n (%) | 149 | 48.9% |
| Gait measures, mean (SD) | ||
| Gait speed, cm/sec | 1.16 | (0.22) |
| Cadence, steps/min | 110.8 | (10.9) |
| Step length, cm | 62.5 | (9.2) |
| Brain volume (ml), mean (SD) | ||
| Total brain volume | 1437.8 | (141.3) |
| Gray matter volume | 483.6 | (62.2) |
| White matter volume | 572.5 | (64.6) |
| WMH volume | 10.9 | (7.7) |
Lawton's Instrumental Activities of Daily Living Scale ≥22/24; SD = standard deviation; WMH = white matter hyperintensities.
Associations between gray and white matter volume and gait measures adjusted for covariates (n = 305).
|
|
| |||||||||||
| Model 1 Adjusted for age, sex and height | Model 2 Additionally adjusted for WMH and normal appearing white matter volume | Model 1 Adjusted for age, sex, height and weight | Model 2 Additionally adjusted for WMH and gray matter volume | |||||||||
|
| β | (95% CI) | P value | β | (95% CI) | P value | β | (95% CI) | P value | β | (95% CI) | P value |
| Gait speed (cm/sec) | 0.08 | (0.04,0.13) | <0.001 | 0.08 | (0.03, 0.13) | 0.001 | 0.04 | (0.00, 0.08) | 0.03 | 0.04 | (−0.0,0.08) | 0.07 |
| Step length (cm) | 0.04 | (0.02,0.05) | <0.001 | 0.04 | (0.02, 0.05) | <0.001 | 0.02 | (0.00, 0.03) | 0.03 | 0.01 | (−0.00,0.02) | 0.06 |
| Cadence (steps/min) | 0.02 | (−0.01,0.04) | 0.12 | 0.02 | (−0.06, 0.04) | 0.15 | 0.01 | (−0.01, 0.03) | 0.27 | 0.01 | (−0.01, 0.03) | 0.35 |
WMH = white matter hyperintensities; β = beta coefficient; CI = confidence intervals.
Figure 1Voxel-based morphometry - regional associations between gray matter atrophy and gait.